vTv Therapeutics Inc. (VTVT)

1.97 -0.03 (-1.5%)

IEX Real-Time Price

March 19, 2019 EST.

NASDAQ Capital Market : Healthcare

Prev Close 2

Price Open 2

Volume: 696,054

Avg Volume: 369,931

Market Cap: 92M

P/E Ratio -2.63

52 Wk Range 0.65-6.09



VTVT Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
38.75M
1.82M
0.25
4.69%

2018-09-28
38.75M
706,355
4.97
1.82%

2018-09-14
36.87M
727,469
6.82
1.97%

2018-08-31
36.87M
729,673
11.82
1.98%




VTVT Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2019-02-26
Q4 2018
N/A
-0.11 (1)
-0.10
0.01

2018-11-08
Q3 2018
N/A
-0.15 (1)
-0.06
0.09

2018-08-03
Q2 2018
N/A
-0.25 (3)
-0.29
-0.04

2018-05-15
Q1 2018
N/A
-0.35 (3)
-0.30
0.05

News

Healthcare names top midday movers (2019-03-18 12:46 SeekingAlpha)

Gainers: Dermira (NASDAQ: DERM ) +85% . PhaseBio Pharmaceuticals (NASDAQ: PHAS ) +48% . Atossa Genetics (NASDAQ: ATOS ) +35% . American Midstream Partners (NYSE: AMID ) +28% . Aclaris Therapeutics (NASDAQ: ACRS ) +21% . Innovate Biopharmaceuticals (NASDAQ: INNT ) +20% . Profess…

 

vTv Therapeutics announces $15M stock financing (2019-03-18 11:21 SeekingAlpha)

Thinly traded vTv Therapeutics slides ( VTVT -14.3% ) as the company enters into an agreement with certain institutional investors for registered direct offering of ~3.6M shares at $1.65/share for gross proceeds of ~$6M More news on: vTv Therapeutics Inc., Healthcare stocks news, …

 

NIHD, LL and ARPO among premarket losers (2019-03-18 09:16 SeekingAlpha)

Aerpio Pharmaceuticals (NASDAQ: ARPO ) -64% after lead candidate flunks mid-stage study. More news on: Aerpio Pharmaceuticals, Inc., NII Holdings, Inc., PolarityTE, Inc., Stocks on the move, Read more …

 

vTv Therapeutics Announces $15 Million of Class A Common Stock Financings (2019-03-18 09:00 Business Wire)

Proceeds Will Fund Start-Up Activities for Current and Future Clinical Trials vTv Therapeutics Inc. (Nasdaq:VTVT) (the Company) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registere…

 


Statistics

Shares Outstanding: 46.7M

Top 15 Institution Percent: 11.30

Price To Sales: 7.51

Price To Book: N/A

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -49.03

Return On Equity: 7.61

Profit Margin: N/A

Price History

Beta: -3.70

50-day Moving Avg: 2.52

200-day Moving Avg: 1.95

YTD Change: -30.14

5-day Change: -7.94

1-month Change: -17.57

3-month Change: 43.80

6-month Change: 143.29

1-year Change: -60.68

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: vTv Therapeutics Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.vtvtherapeutics.com

vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes. Its other products include TTP399, type II diabetes drug candidate.